Tennessee · 114
SB 2586
Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
Bill record: Open States bulk CSV (bills/votes) CC0-1.0
Summary AI-generated
Tennessee SB 2586 authorizes physicians to perform stem cell or regenerative medicine therapies not approved by the U.S. Food and Drug Administration, provided the therapy falls within the physician's scope of practice. The bill amends Tennessee Code Annotated Titles 63 and 68 to make related changes.
Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Open States bulk CSV (bills/votes) CC0-1.0 GovTally LLM enrichment (local oMLX)
Issue tags AI-classified
Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)
Sponsors
- Ed Jackson Republican lead
Roll-call votes on this bill
| Question | Chamber | Result | Yea | Nay | Other | Date | Source |
|---|---|---|---|---|---|---|---|
| SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s… | upper | pass | 0 | 0 | 0 | Apr 1, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |